|
| Adverse event | Baseline risk
without steroids | Risk 34–36 weeks
with steroids |
|
Chronic respiratory
disease | 0.07 [14]
(0.03–0.14) | 0.0602 [2, 14]
(0.0258–0.1204) |
| Death in childhood | 0.00642 [15]
(0.0059–0.0069) | 0.0043656 [2, 15]
(0.004012–0.004692) |
Neurodevelopmental
delay in childhood | 0.00246 [16]
(0.0022–0.0028) | 0.0015744 [2, 16]
(0.001408–0.001792) |
|